STOCK TITAN

Acadia Healthcare (ACHC) director granted 6,331 new shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Acadia Healthcare Company, Inc. director Ralph David Kelly received a grant of 6,331 shares of Common Stock on May 6, 2026. The award carries no cash purchase price and represents a grant, award, or other acquisition of shares. These shares will vest over three years in equal yearly installments beginning May 6, 2027. Following this grant, Kelly directly holds 26,358 shares of Acadia Healthcare common stock.

Positive

  • None.

Negative

  • None.
Insider KELLY RALPH DAVID
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 6,331 $0.00 $0.00
Holdings After Transaction: Common Stock — 26,358 shares (Direct)
Footnotes (1)
  1. F1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
Shares granted 6,331 shares Common Stock grant on May 6, 2026
Post-transaction holdings 26,358 shares Directly owned after the grant
Grant price per share $0.0000 per share Indicates award, not market purchase
Vesting period 3 years Equal yearly installments beginning May 6, 2027
Grant, award, or other acquisition financial
"transaction code description is "Grant, award, or other acquisition""
vesting financial
"Shares will vest over a 3-year period in equal yearly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did ACHC director Ralph David Kelly report?

Ralph David Kelly reported receiving a grant of 6,331 Acadia Healthcare common shares on May 6, 2026. The Form 4 classifies this as a grant, award, or other acquisition, increasing his direct holdings to 26,358 shares after the transaction.

How many Acadia Healthcare (ACHC) shares does Ralph David Kelly now hold?

After the reported grant, Ralph David Kelly directly holds 26,358 shares of Acadia Healthcare common stock. This reflects the addition of 6,331 shares awarded on May 6, 2026, as disclosed in the Form 4 insider filing.

Is the ACHC insider transaction a market purchase or a share award?

The ACHC insider transaction is a share award, not a market purchase. The Form 4 lists transaction code A, described as a grant, award, or other acquisition, with a price per share of 0.0000, indicating no open-market buying.

What is the vesting schedule for Ralph David Kelly’s new ACHC shares?

The 6,331 granted ACHC shares will vest over a three-year period. According to the footnote, they vest in equal yearly installments beginning May 6, 2027, meaning one-third of the award becomes vested each year over that timeframe.

Does the ACHC Form 4 show any stock sales by Ralph David Kelly?

The Form 4 does not report any stock sales by Ralph David Kelly. It shows a single acquisition transaction coded as a grant, award, or other acquisition of 6,331 common shares, with no dispositions or sales recorded in this filing.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KELLY RALPH DAVID

(Last)(First)(Middle)
4020 ASPEN GROVE DRIVE, SUITE 900

(Street)
FRANKLIN TENNESSEE 37067

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/06/2026A6,331(1)A$0.026,358D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
/s/ Brian Farley as Attorney in Fact for Ralph David Kelly05/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)